Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04399707 · ClinicalTrials.gov registry record · NA
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
A NA study of Analgesia and Cesarean Section, sponsored by Hawaii Pacific Health.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT04399707: Recruiting NA study of Analgesia and Cesarean Section, sponsored by Hawaii Pacific Health.
NCT04399707 is a NA study of Analgesia and Cesarean Section that is actively recruiting participants, run by Hawaii Pacific Health. The registered enrollment target is 180 participants, above the 83-participant average among 19 other Analgesia trials with a reported enrollment target (117% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04399707, a NA study of Analgesia and Cesarean Section, is actively recruiting participants, sponsored by Hawaii Pacific Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose of study is to evaluate the efficacy of transcutaneous electrical nerve stimulation (TENS) for post-operative pain control after a cesarean delivery compared to placebo and no TENS.
Primary Outcome
Total postoperative narcotic consumption (measured in morphine equivalents)
Conditions Studied
Interventions
- DEVICE Transcutaneous electrical nerve stimulation (TENS) unit
- DEVICE Placebo transcutaneous electrical nerve stimulation (TENS) unit
Study Locations (1)
Hawaii
- Nicole Kurata - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-01-29 |
| Est. Completion | 2021-05 |
| Phase | NA |
What NCT04399707 shows while recruiting
NCT04399707 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 19 other Analgesia trials with a reported enrollment target (117% higher).
The record links to 3 conditions, with Analgesia appearing as the primary indexed condition, and to 2 interventions - of which Transcutaneous electrical nerve stimulation (TENS) unit is the first listed.
NCT04399707 reports a single indexed study location in Hawaii.
Frequently Asked Questions
What is clinical trial NCT04399707 about?
NCT04399707 is a clinical study titled "Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control". Purpose of study is to evaluate the efficacy of transcutaneous electrical nerve stimulation (TENS) for post-operative pain control after a cesarean delivery compared to placebo and no TENS.
What is the current status of trial NCT04399707?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2020-01-29. Estimated completion is 2021-05.
What conditions does trial NCT04399707 study?
This clinical trial studies the following conditions: Analgesia, Cesarean Section, Transcutaneous Electric Nerve Stimulation.
What interventions are being tested in trial NCT04399707?
The interventions under investigation include: Transcutaneous electrical nerve stimulation (TENS) unit (DEVICE), Placebo transcutaneous electrical nerve stimulation (TENS) unit (DEVICE).
Who is sponsoring clinical trial NCT04399707?
This trial is sponsored by Hawaii Pacific Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04399707 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04399707's enrollment target sits among peer trials
180 1st of 19 the highest of 19 other Analgesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Analgesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TENS Unit for Analgesia During IUD Insertion
RECRUITING · NA
-
Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery
RECRUITING · NA
-
Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
RECRUITING · NA
-
Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks
RECRUITING · NA
-
High Level Pulsed Heat Versus Low Level Steady Heat in Subjects With Chronic Low Back Pain
COMPLETED · NA
-
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI